<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In cases of thrombotic <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> the leucergic and thrombergic tests were done on the 2nd and 3d days of the disease and after 48 hours from the first <z:chebi fb="0" ids="52071">dextran</z:chebi> loading </plain></SENT>
<SENT sid="1" pm="."><plain>Fleck's test tube method was used in the leucergy test </plain></SENT>
<SENT sid="2" pm="."><plain>The proportion of agglutinated platelets was calculated from a smear stained by Papanicolau method </plain></SENT>
<SENT sid="3" pm="."><plain>The results were processed statistically </plain></SENT>
<SENT sid="4" pm="."><plain>An inhibitory effect of <z:chebi fb="0" ids="52071">dextran</z:chebi> on aggregation of white blood cells and platelets was observed in the blood of patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The inhibitory effects of <z:chebi fb="0" ids="52071">dextran</z:chebi> was greater in relation to aggregation of platelets than white blood cells </plain></SENT>
<SENT sid="6" pm="."><plain>However, in our investigations the effect of this agent on both processes was transient </plain></SENT>
</text></document>